Clinical and Laboratory Predictors of Major Adverse Cardiac Events in Patients with Ischemic Heart Disease Following Elective Percutaneous Coronary Intervention
Background. Despite recent advances in stent design and constantly improving protective pharmacological strategies, complications and adverse events following percutaneous coronary interventions (PCI) are still major factors influencing morbidity and mortality. Therefore, predicting secondary vascul...
Main Authors: | E. Z. Golukhova, M. V. Grigoryan, M. N. Ryabinina, N. I. Bulaeva |
---|---|
Format: | Article |
Language: | English |
Published: |
Столичная издательская компания
2016-11-01
|
Series: | Рациональная фармакотерапия в кардиологии |
Subjects: | |
Online Access: | https://www.rpcardio.online/jour/article/view/1332 |
Similar Items
-
THE EFFECTS OF SHORT/LONG-TERM ADMINISTRATION OF DUAL ANTIPLATELET THERAPY ON RESTENOSIS IN PATIENTS WITH CAROTID ARTERY STENTING
by: İsmail Karluka, et al.
Published: (2022-12-01) -
Vascular Wall Reactions to Coronary Stents—Clinical Implications for Stent Failure
by: Tommaso Gori
Published: (2021-01-01) -
Restenosis after Coronary Stent Implantation: Cellular Mechanisms and Potential of Endothelial Progenitor Cells (A Short Guide for the Interventional Cardiologist)
by: Tommaso Gori
Published: (2022-06-01) -
OPTIMA Tacrolimus-eluting Stent: A Twelve-month Clinical Follow up with Two Different Periods of Dual Antiplatelet Therapy; 2-monthvs. 6-month Approach
by: Nasser Aslanabadi, et al.
Published: (2012-09-01) -
Mechanism of Drug-Eluting Stent Thrombosis Diagnosed by Histopathological Evaluation of Directional Coronary Atherectomy Specimen
by: Kazuki Ito, MD, et al.
Published: (2023-12-01)